% | $
Quotes you view appear here for quick access.

ZAGG Inc Message Board

rxonman 1 post  |  Last Activity: Mar 3, 2015 10:28 PM Member since: Feb 21, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • as I take it, one dosing level is showing good results. however, w only total 75 participants and 3 dosing cohorts, each is only 25 w 50% getting drug. therefore a request for 20 in only one group suggests attempt to confirm efficacy with 10 more patients getting drug. this group, 25 + 20 for 45 will provide the data on which to base phase 3 trial. I believe that's why stock took off at end of day. tell me why I am wrong.
    oh, and any delay is more than made up by positive signal for efficacy and value that bestows. if no efficacy, study would have been completed w/o request or more info and p2 data would have been a bust. imho

8.79-0.12(-1.35%)Apr 28 4:00 PMEDT